ADAWI KAMAL (Chief Financial Officer) received a stock award from FATE THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/16/2026ACC: 0001193125-26-015323
Officer· Chief Financial Officer
Since Oct 2025
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
33.3%
1/15/2026
75K→100K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2026 | A · Award | +25K | — | — | 33.3% | 75K | 100K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
1.05
Held after
75K
Exercisable
—
1/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock75K shares | 1/15/2026 | A · Award | +75K | 1.05 | — | 75K |